Stay updated on DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s revision/version marker was updated from v3.5.2 to v3.5.3, reflecting a software release on the site.
    Difference
    0.0%
    Check dated 2026-04-26T15:23:12.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-19T13:43:24.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added. Revision: v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-21T19:55:42.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T08:00:42.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, replacing v3.4.1; no core study content or user-facing details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:24:19.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.4.1 appears on the page, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:35:33.000Z thumbnail image

Stay in the know with updates to DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DS8201a and Pembrolizumab in Advanced Cancer Clinical Trial page.